These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27708683)

  • 1. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats.
    Zhang H; Shen WJ; Li Y; Bittner A; Bittner S; Tabassum J; Cortez YF; Kraemer FB; Azhar S
    Nutr Metab (Lond); 2016; 13():63. PubMed ID: 27708683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
    Zhang H; Li Y; Hu J; Shen WJ; Singh M; Hou X; Bittner A; Bittner S; Cortez Y; Tabassum J; Kraemer FB; Azhar S
    PLoS One; 2015; 10(9):e0138203. PubMed ID: 26394137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
    Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats.
    Singh M; Bittner S; Li Y; Bittner A; Han L; Cortez Y; Inayathullah M; Arif Z; Parthasarathi R; Rajadas J; Shen WJ; Nicolls MR; Kraemer FB; Azhar S
    Br J Pharmacol; 2019 Feb; 176(3):369-385. PubMed ID: 30374952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nordihydroguaiaretic Acid, a Lignan from
    Chan JKW; Bittner S; Bittner A; Atwal S; Shen WJ; Inayathullah M; Rajada J; Nicolls MR; Kraemer FB; Azhar S
    J Pharmacol Exp Ther; 2018 May; 365(2):281-290. PubMed ID: 29472517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
    Han L; Bittner S; Dong D; Cortez Y; Dulay H; Arshad S; Shen WJ; Kraemer FB; Azhar S
    Mol Cell Endocrinol; 2019 Dec; 498():110538. PubMed ID: 31415794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
    Scribner KA; Gadbois TM; Gowri M; Azhar S; Reaven GM
    Metabolism; 2000 Sep; 49(9):1106-10. PubMed ID: 11016888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
    Shimada M; Hibino M; Takeshita A
    Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
    Lee MS; Kim D; Jo K; Hwang JK
    Biochem Biophys Res Commun; 2010 Oct; 401(1):92-7. PubMed ID: 20836990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
    Roglans N; Sanguino E; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
    Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
    Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression.
    Sangüesa G; Montañés JC; Baena M; Sánchez RM; Roglans N; Alegret M; Laguna JC
    Eur J Nutr; 2019 Apr; 58(3):1283-1297. PubMed ID: 29516226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Grape Seed Procyanidin Extract Ameliorates Fructose-Induced Hypertriglyceridemia in Rats via Enhanced Fecal Bile Acid and Cholesterol Excretion and Inhibition of Hepatic Lipogenesis.
    Downing LE; Heidker RM; Caiozzi GC; Wong BS; Rodriguez K; Del Rey F; Ricketts ML
    PLoS One; 2015; 10(10):e0140267. PubMed ID: 26458107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis.
    Kang SA; Hong K; Jang KH; Kim YY; Choue R; Lim Y
    J Nutr Biochem; 2006 Jun; 17(6):419-26. PubMed ID: 16214330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress.
    Baena M; Sangüesa G; Hutter N; Sánchez RM; Roglans N; Laguna JC; Alegret M
    Biochim Biophys Acta; 2015 Feb; 1851(2):107-16. PubMed ID: 25463011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
    Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
    Liang Y; She P; Wang X; Demarest K
    Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.